139 related articles for article (PubMed ID: 21325085)
1. Survival after bronchiolitis obliterans syndrome.
Yerkovich ST; Hopkins PM; Chambers DC
Am J Respir Crit Care Med; 2011 Feb; 183(4):554; author reply 554-5. PubMed ID: 21325085
[No Abstract] [Full Text] [Related]
2. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
3. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
5. Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS.
Paantjens AW; van de Graaf EA; van Ginkel WG; van den Bosch JM; Otten HG
J Heart Lung Transplant; 2010 May; 29(5):596-8. PubMed ID: 20207170
[No Abstract] [Full Text] [Related]
6. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
[TBL] [Abstract][Full Text] [Related]
7. [Lung transplantation and rejection. Basic principles, clinical aspects and histomorphology].
Wohlschläger J; Sommerwerck U; Jonigk D; Rische J; Baba HA; Müller KM
Pathologe; 2011 Mar; 32(2):104-12. PubMed ID: 21424408
[TBL] [Abstract][Full Text] [Related]
8. FK506 rescue therapy in lung transplantation.
Wiebe K; Harringer W; Franke U; Strüber M; Krug N; Korff F; Wahlers T; Cremer J; Haverich A
Transplant Proc; 1998 Jun; 30(4):1508-9. PubMed ID: 9636613
[No Abstract] [Full Text] [Related]
9. [Immunosuppression after heart and lung transplantation].
Wendler O; Schäfers HJ
Med Klin (Munich); 1997 Dec; 92 Suppl 5():3-7. PubMed ID: 19479389
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant bronchiolitis obliterans syndrome. Where have we been and where are we going?
Dauber JH
Chest; 1996 Apr; 109(4):857-9. PubMed ID: 8635356
[No Abstract] [Full Text] [Related]
11. Apoptosis in bronchiolitis obliterans, chronic rejection and infection after lung transplantation in rats.
Yagyu K; van Breda Vriesman PJ
Transplant Proc; 1997; 29(1-2):1532-5. PubMed ID: 9123414
[No Abstract] [Full Text] [Related]
12. Early treatment of acute rejection prevents chronic rejection in a rat model of allogenic left lung transplantation.
Hirt SW; You XM; Möller F; Boeke K; Ernst M; Starke M; Spranger U; Wottge HU
Transplant Proc; 1998 Jun; 30(4):1005-6. PubMed ID: 9636406
[No Abstract] [Full Text] [Related]
13. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.
Roman A; Bravo C; Monforte V; Reyes L; Canela M; Morell F
Transplant Proc; 2002 Feb; 34(1):146-7. PubMed ID: 11959227
[No Abstract] [Full Text] [Related]
14. Acute rejection and humoral sensitization in lung transplant recipients.
Martinu T; Chen DF; Palmer SM
Proc Am Thorac Soc; 2009 Jan; 6(1):54-65. PubMed ID: 19131531
[TBL] [Abstract][Full Text] [Related]
15. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
Weigt SS; Wallace WD; Derhovanessian A; Saggar R; Saggar R; Lynch JP; Belperio JA
Semin Respir Crit Care Med; 2010 Apr; 31(2):189-207. PubMed ID: 20354932
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.
Speich R; Schneider S; Hofer M; Irani S; Vogt P; Weder W; Boehler A
Pulm Pharmacol Ther; 2010 Oct; 23(5):445-9. PubMed ID: 20394831
[TBL] [Abstract][Full Text] [Related]
17. A chronic large animal model of lung allograft rejection.
Schmid RA; Kwong K; Boasquevisque CH; Wick M; Patterson GA; Sundt TM
Transplant Proc; 1997; 29(1-2):1521. PubMed ID: 9123409
[No Abstract] [Full Text] [Related]
18. Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation.
Neurohr C; Huppmann P; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Uberfuhr P; Bittmann I; Behr J; Reichart B;
Transpl Int; 2009 Jun; 22(6):635-43. PubMed ID: 19207186
[TBL] [Abstract][Full Text] [Related]
19. Invited commentary.
Bhorade S
Ann Thorac Surg; 2014 Jan; 97(1):274-5. PubMed ID: 24384177
[No Abstract] [Full Text] [Related]
20. ATG induction therapy and the incidence of bronchiolitis obliterans after lung transplantation: does it make a difference?
Wiebe K; Harringer W; Wahlers T; Franke U; Strüber M; Hamm M; Cremer J; Haverich A
Transplant Proc; 1998 Jun; 30(4):1517-8. PubMed ID: 9636617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
